APA (7th ed.) Citation

Chieko Michikawa, D., Pedro A. Torres-Saavedra, P., Natalie L. Silver, M., Paul M. Harari, M., Merrill S. Kies, M., David I. Rosenthal, M., . . . Jeffrey N. Myers, M. (2022). Evolutionary Action Score of TP53 Analysis in Pathologically High-Risk Human Papillomavirus-Negative Head and Neck Cancer From a Phase 2 Clinical Trial: NRG Oncology Radiation Therapy Oncology Group 0234. Elsevier.

Chicago Style (17th ed.) Citation

Chieko Michikawa, DDS, et al. Evolutionary Action Score of TP53 Analysis in Pathologically High-Risk Human Papillomavirus-Negative Head and Neck Cancer From a Phase 2 Clinical Trial: NRG Oncology Radiation Therapy Oncology Group 0234. Elsevier, 2022.

MLA (9th ed.) Citation

Chieko Michikawa, DDS, et al. Evolutionary Action Score of TP53 Analysis in Pathologically High-Risk Human Papillomavirus-Negative Head and Neck Cancer From a Phase 2 Clinical Trial: NRG Oncology Radiation Therapy Oncology Group 0234. Elsevier, 2022.